Heart Disease News and Research

Latest Heart Disease News and Research

Study to quantify benefits of aerobic exercise in managing Parkinson's symptoms

Daniel Corcos has studied Parkinson's disease for more than 20 years. For most of the past 10, he has focused on the effects of exercise. "It became obvious several years ago that exercise really was good for people with Parkinson's disease," said Corcos, who is professor of kinesiology and nutrition at the University of Illinois at Chicago. "Not only is it good for the heart, the brain, and muscles in the same way it is for healthy people, it also modifies signs and symptoms of Parkinson's disease."

17 Feb 2012

Researchers test nanoscale carbon clusters for cancer chemotherapy

A mixture of current drugs and carbon nanoparticles shows potential to enhance treatment for head-and-neck cancers, especially when combined with radiation therapy, according to new research by Rice University and the University of Texas MD Anderson Cancer Center.

16 Feb 2012

Pfizer, Mylan enter settlement agreement to resolve e-cue patent litigation

Mylan Inc. and Pfizer Inc. today announced that Meridian Medical Technologies, a Pfizer subsidiary, has entered into a settlement agreement with Intelliject and Sanofi-Aventis that will resolve pending patent litigation related to Intelliject's 505(b)(2) new drug application (NDA) for its epinephrine auto-injector known as e-cue, which will be manufactured and marketed by Sanofi-Aventis.

16 Feb 2012

Acorda's fourth quarter GAAP net income increases to $12.7 million

Acorda Therapeutics, Inc. today announced its financial results for the fourth quarter and full year ended December 31, 2011.

16 Feb 2012

Delivery of particle accelerator marks key milestone for making medical isotopes with X-rays

A research project exploring the potential for making medical isotopes with X-rays from a particle accelerator instead of a nuclear reactor is about to move to the large scale.

16 Feb 2012

HeartWare revenues for fiscal 2011 increase to $82.8 million

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, announced revenue of $23.1 million for the fourth quarter ended December 31, 2011, as compared to $20.9 million for the fourth quarter of 2010.

16 Feb 2012

NCQA tool doesn't adequately evaluate quality of diabetes care at health centers

On the health front, the poor often have at least two things going against them: a lack of insurance and chronic illnesses, of which diabetes is among the most common.

16 Feb 2012

Study aims to eradicate the most common cause of food poisoning

Eliminating the most common cause of food poisoning from the food chain is the aim of new research funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and the world-leading UK-based poultry breeding company Aviagen.

16 Feb 2012

Controversy over psychiatric diagnosis reaches a fever pitch

As the Diagnostic and Statistical Manual of Mental Disorders is revised for the first time since 1994, controversy about psychiatric diagnosis is reaching a fever pitch.

16 Feb 2012

Diet exerts a strong influence on heart health

Food is your friend and your biggest foe. A healthy diet sustains us, but a poor diet can raise blood pressure, cholesterol, blood sugar levels and weight and put you at risk for heart disease.

16 Feb 2012

Drilling down into Obama's budget

The Wall Street Journal reports the plan would scale back money for public health and prevention programs; The Associated Press covers the debate about the proposed defense budget, which would scale back retirees' health coverage.

16 Feb 2012

China's SFDA approves Affymetrix GeneChip System 3000Dx v.2

Affymetrix, Inc. today announced that its GeneChip System 3000Dx v.2 (GCS 3000Dx v.2) has been approved by China's State Food and Drug Administration (SFDA) for in vitro diagnostic use.

16 Feb 2012

Thrombocytosis linked to severity of ovarian cancer

Highly elevated platelet levels fuel tumor growth and reduce the survival of ovarian cancer patients, an international team of researchers led by scientists at The University of Texas MD Anderson Cancer center reports in the New England Journal of Medicine.

16 Feb 2012

Pure Health launches new fresh freeze dried Black Raspberry capsules

Pure Health, a leading online provider of pure, authentic superfruit supplements, launched today a new fresh freeze dried 100 percent pure Black Raspberry capsule supplement.

16 Feb 2012

UCSF stem cell study suggests novel strategy for heart attack

A UCSF stem cell study conducted in mice suggests a novel strategy for treating damaged cardiac tissue in patients following a heart attack. The approach potentially could improve cardiac function, minimize scar size, lead to the development of new blood vessels - and avoid the risk of tissue rejection.

16 Feb 2012

Study finds poor QOL in South Asians with coronary artery disease

In a first-of-its-kind study in Canada, Kevin Bainey of the Faculty of Medicine & Dentistry has discovered that South Asians who live in Alberta with coronary disease experience a lower quality of life.

16 Feb 2012

Direct link between short telomere length, heart attack and early death

Every cell in the body has chromosomes with so-called telomeres, which are shortened over time and also through lifestyle choices such as smoking and obesity. Researchers have long speculated that the shortening of telomeres increases the risk of heart attack and early death. Now a large-scale population study in Denmark involving nearly 20,000 people shows that there is in fact a direct link, and has also given physicians a future way to test the actual cellular health of a person.

16 Feb 2012

Baby Jaya receives a pacemaker 15 mins after birth

Little Jaya lived up to her name which in Hindi means victorious. Jaya Maharaj became one of the smallest recipients of a pacemaker when she was just 15 minutes old.

15 Feb 2012

St. Jude Medical to examine cost-effectiveness of FFR-guided therapy in Australia, Asia

St. Jude Medical, Inc., a global medical device company, announced today it will evaluate the incremental cost-effectiveness of Fractional Flow Reserve (FFR)-guided treatment for patients with multivessel coronary artery disease in Japan, China, India, Korea, and Australia.

15 Feb 2012

Patient feedback on how NHS hospitals are doing important

Patients are reportedly happy with the services they received at the Weston General Hospital outpatient department. The survey of 850 patients revealed Weston Area Health NHS Trust has improved in 13 areas since the last survey in 2009 and performs significantly better than other NHS trusts in 12 areas.

15 Feb 2012